IP Verse

Nicotine Pouch Composition And Pouch Comprising Such - EP3773494

The patent EP3773494 was granted to Fertin Pharma on Apr 6, 2022. The application was originally filed on Jun 5, 2020 under application number EP20732727A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3773494

FERTIN PHARMA
Application Number
EP20732727A
Filing Date
Jun 5, 2020
Status
Granted And Under Opposition
Mar 4, 2022
Publication Date
Apr 6, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NICOVENTURESJan 6, 2023D YOUNGADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2692254
DESCRIPTIONGB673587
DESCRIPTIONUS5167244
DESCRIPTIONWO2008152469
EXAMINATIONWO2020157280
INTERNATIONAL-SEARCH-REPORTWO2010121619
INTERNATIONAL-SEARCH-REPORTWO2018197454
OPPOSITIONWO2011150959
OPPOSITIONWO2011150960
OPPOSITIONWO2013147687
OPPOSITIONWO2018197454
OPPOSITIONWO2018233795
OPPOSITIONWO2020157280

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Echa, "2-Propenoic acid, 2-methyl-, polymer with diethenylbenzene, compd. with 3-((2S)-l-methyl-2- pyrrolinidinyl)pyridine", Substance Information - ECHA, (20090101), pages 1 - 3, Substance Information - ECHA, URL: https://echa.europa.eu/substance-information/-/substanceinfo/100.127.753, (20231211), XP093110632
OPPOSITION- Owens Sonia, "Nicotine Polacrilex, 20%", Spectrum - MSDF, (20100607), pages 1 - 7, Spectrum - MSDF, (20230123), XP093016540
OPPOSITION- Patel J. B., "Nicotine Polacrilex USP/Nicotine Resinate EP (Contains 20% Nicotine) ", BGP HEALTHCARE PRIVATE LIMITED - SDS, (20200101), pages 1 - 8, BGP HEALTHCARE PRIVATE LIMITED - SDS, (20230123), XP093016542

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents